Details for New Drug Application (NDA): 212695
✉ Email this page to a colleague
The generic ingredient in LIDOCAINE is epinephrine; lidocaine hydrochloride. There are twenty-one drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.
Summary for 212695
Tradename: | LIDOCAINE |
Applicant: | Quagen |
Ingredient: | lidocaine |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 212695
Physiological Effect | Local Anesthesia |
Medical Subject Heading (MeSH) Categories for 212695
Suppliers and Packaging for NDA: 212695
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LIDOCAINE | lidocaine | OINTMENT;TOPICAL | 212695 | ANDA | QUAGEN PHARMACEUTICALS LLC | 70752-113 | 70752-113-03 | 1 TUBE in 1 CARTON (70752-113-03) / 35.44 g in 1 TUBE |
LIDOCAINE | lidocaine | OINTMENT;TOPICAL | 212695 | ANDA | QUAGEN PHARMACEUTICALS LLC | 70752-113 | 70752-113-04 | 50 g in 1 JAR (70752-113-04) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | OINTMENT;TOPICAL | Strength | 5% | ||||
Approval Date: | Apr 20, 2021 | TE: | AT | RLD: | No |
Complete Access Available with Subscription